Pay in 4 interest-free payments of $29.75 Learn more
Ships within 48 hours · Estimated delivery Sep 18 - Sep 23
oral dosing of Ravoxertinib results in significant single-agent activity in multiple in vivo cancer models
3)27-23(28)21(22(31(27
AM211 (10 mg/kg
C4H4O4/c1-4-28-20(25)18-15(11-27-10-9-22)23-12(2)16(19(24)26-3)17(18)13-7-5-6-8-14(13)21
A significant reduction of phospho-SRCY416 is observed in the xenograft sections from mice treated with eCF506 relative to the untreated animal controls
Cannabidiol dimethyl ether Catalog No.:M22342-C oral dosing of Ravoxertinib resultsCannabidiol dimethyl ether (CBDD) is a cannabidiol derivative that potently and selectively inhibits 15 LOX with an IC50 value of 0. 28 M. 15 LOX can oxygenate cholesterol esters in the low density lipoprotein (LDL) particle. Thus, 15 LOX has been involved in the development of atherosclerosis, and CBDD may be a useful prototype for producing medicines for atherosclerosis . CBDD showed a potent inhibitory effect on the catalytic activity of cytochrome
US$ 180.00
US$ 86.95
US$ 107.50
US$ 93.00
US$ 35.95